INS and inflammatory bowel disease: This apparent lack of correlation can be explained by the findings of Bregenzer et al. [26] of increased insulin secretion in patients with IBD (specifically CD patients), secondary to the up-regulatory effect of the entero-pancreatic axis on beta cell function.